Corisande Baldwin
Overview
Explore the profile of Corisande Baldwin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turgeon D, Bakowsky V, Baldwin C, Cabral D, Clements-Baker M, Clifford A, et al.
Rheumatology (Oxford)
. 2023 Feb;
62(8):2646-2651.
PMID: 36805625
Objective: In 2020, the Canadian Vasculitis Research Network (CanVasc) published their updated recommendations for the management of ANCA-associated vasculitides (AAV). The current addendum provides further recommendations regarding the use of...
2.
Rebic N, Munro S, Garg R, Hazlewood G, Amiri N, Baldwin C, et al.
Arthritis Res Ther
. 2022 Jan;
24(1):31.
PMID: 35065668
Objective: To examine how female patients with RA form decisions about having children, pregnancy, and medication use. Methods: We employed a constructivist grounded theory design and recruited female participants who...
3.
Garg R, Rebic N, Amiri N, Hazlewood G, Baldwin C, Ensworth S, et al.
Rheumatol Adv Pract
. 2021 Sep;
5(3):rkab040.
PMID: 34557621
Objective: Partners of patients with RA often take on supportive roles given the debilitating nature of RA. Our objective was to explore the perspectives, attitudes and experiences of partners of...
4.
Mendel A, Ennis D, Go E, Bakowsky V, Baldwin C, Benseler S, et al.
J Rheumatol
. 2020 Sep;
48(4):555-566.
PMID: 32934123
Objective: In 2015, the Canadian Vasculitis Research Network (CanVasc) created recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) in Canada. The current update aims to revise existing...
5.
Howren A, Rebic N, Sayre E, Tsao N, Amiri N, Baldwin C, et al.
Clin Exp Rheumatol
. 2020 Mar;
38(6):1080-1087.
PMID: 32141437
Objectives: Epidemiologic studies evaluating associations between specific arthritis medications and perinatal outcomes are limited. We evaluated the association between conventional synthetic DMARD (csDMARD) use among women with rheumatic disease (RD)...
6.
Chew C, Rebic N, Baldwin C, Amiri N, Proulx L, De Vera M
ACR Open Rheumatol
. 2019 Nov;
1(8):485-492.
PMID: 31777829
Objective: Rheumatoid arthritis (RA) disproportionately affects more women than men, often striking during childbearing years. Because the Internet, particularly social media, is increasingly used by patients with chronic conditions seeking...
7.
Rebic N, Sayre E, Zusman E, Amiri N, Baldwin C, De Vera M
Rheumatology (Oxford)
. 2019 Oct;
59(7):1514-1521.
PMID: 31628479
Objectives: To characterize the utilization and discontinuation of medications before, during and after pregnancy among women with RA. Methods: We used population-based administrative data to identify women with RA who...
8.
Baldwin C, Mohammad A, Cousins C, Carette S, Pagnoux C, Jayne D
Rheumatol Adv Pract
. 2019 Aug;
2(2):rky026.
PMID: 31431972
Objective: To describe the long-term outcomes of patients with Takayasu arteritis (TAK) and renal artery involvement (RAI). Methods: A retrospective review of 122 patients with TAK at three tertiary centres...
9.
De Vera M, Baldwin C, Tsao N, Howren A, Hazlewood G, Rebic N, et al.
BMC Rheumatol
. 2019 May;
3:18.
PMID: 31143850
Background: With improved therapies and management, more women with inflammatory arthritides (IA) are considering pregnancy. Our objective was to survey rheumatologists across Canada about their IA management in pregnancy to...
10.
Baldwin C, Avina-Zubieta A, Rai S, Carruthers E, De Vera M
Clin Exp Rheumatol
. 2016 Mar;
34(2):172-83.
PMID: 26940667
Objectives: Despite the high incidence of rheumatic diseases during the reproductive years, little is known about the impact of disease-modifying anti-rheumatic drug (DMARD) use during pregnancy. Our objective was to...